{"transactions":[{"id":881307,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":64670,"kind":"person","name":"Jones Jeffrey Alan","position":1,"cik":"0001914647","reported_name":"Jones Jeffrey Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-25T22:00:04.000Z","date":"2026-02-24","kind":"sale","planned":false,"acquired":false,"shares":4582,"price":14.47,"value":66301.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover personal income tax obligations upon vesting of restricted stock units."}],"balance_after":159968,"source":{"system":"sec-edgar","filing":"0001193125-26-072000","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000119312526072000/ownership.xml","form_type":"4"}},{"id":887430,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":64670,"kind":"person","name":"Jones Jeffrey Alan","position":1,"cik":"0001914647","reported_name":"Jones Jeffrey Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-23T22:00:09.000Z","date":"2026-02-20","kind":"sale","planned":false,"acquired":false,"shares":4982,"price":13.62,"value":67854.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover personal income tax obligations upon vesting of restricted stock units."}],"balance_after":164550,"source":{"system":"sec-edgar","filing":"0001193125-26-064257","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000119312526064257/ownership.xml","form_type":"4"}},{"id":892412,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":64670,"kind":"person","name":"Jones Jeffrey Alan","position":1,"cik":"0001914647","reported_name":"Jones Jeffrey Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-19T22:00:09.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option vest over four years, with one forty-eighth (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date."}],"balance_after":300000,"derivative":{"exercise_price":12.44,"expiration_date":"2036-02-18","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001193125-26-059640","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000119312526059640/ownership.xml","form_type":"4"}},{"id":961720,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":64670,"kind":"person","name":"Jones Jeffrey Alan","position":1,"cik":"0001914647","reported_name":"Jones Jeffrey Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-12-19T22:00:14.000Z","date":"2025-12-18","kind":"sale","planned":false,"acquired":false,"shares":4632,"price":9.67,"value":44791.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover personal income tax obligations upon vesting of restricted stock units."}],"balance_after":169532,"source":{"system":"sec-edgar","filing":"0001193125-25-327030","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000119312525327030/ownership.xml","form_type":"4"}},{"id":1240058,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":64670,"kind":"person","name":"Jones Jeffrey Alan","position":1,"cik":"0001914647","reported_name":"Jones Jeffrey Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-02-27T22:00:09.000Z","date":"2025-02-25","kind":"sale","planned":false,"acquired":false,"shares":4895,"price":8.53,"value":41754.35,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover personal income tax obligations upon vesting of restricted stock units."}],"balance_after":174164,"source":{"system":"sec-edgar","filing":"0000950170-25-029201","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000095017025029201/ownership.xml","form_type":"4"}},{"id":1252098,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":64670,"kind":"person","name":"Jones Jeffrey Alan","position":1,"cik":"0001914647","reported_name":"Jones Jeffrey Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-21T23:00:04.000Z","date":"2025-02-19","kind":"grant","planned":false,"acquired":true,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the option vest over four years, with one forty-eighth (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date."}],"balance_after":130000,"derivative":{"exercise_price":9.43,"expiration_date":"2035-02-19","underlying":"Common Stock","underlying_shares":130000},"source":{"system":"sec-edgar","filing":"0000950170-25-025028","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000095017025025028/ownership.xml","form_type":"4"}},{"id":1252097,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":64670,"kind":"person","name":"Jones Jeffrey Alan","position":1,"cik":"0001914647","reported_name":"Jones Jeffrey Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-02-21T23:00:04.000Z","date":"2025-02-19","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares underlying the restricted stock unit vest on an annual basis over four years."}],"balance_after":179059,"source":{"system":"sec-edgar","filing":"0000950170-25-025028","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000095017025025028/ownership.xml","form_type":"4"}},{"id":1323785,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":64670,"kind":"person","name":"Jones Jeffrey Alan","position":1,"cik":"0001914647","reported_name":"Jones Jeffrey Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-12-20T22:00:06.000Z","date":"2024-12-18","kind":"sale","planned":false,"acquired":false,"shares":4632,"price":11.41,"value":52851.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover personal income tax obligations upon vesting of restricted stock units."}],"balance_after":114059,"source":{"system":"sec-edgar","filing":"0000950170-24-139124","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000095017024139124/ownership.xml","form_type":"4"}},{"id":1621642,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":64670,"kind":"person","name":"Jones Jeffrey Alan","position":1,"cik":"0001914647","reported_name":"Jones Jeffrey Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-23T22:00:15.000Z","date":"2024-02-22","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the option vest over four years, with one forty-eighth (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date."}],"balance_after":125000,"derivative":{"exercise_price":17.54,"expiration_date":"2034-02-22","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0000950170-24-019455","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000095017024019455/ownership.xml","form_type":"4"}},{"id":1621641,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":64670,"kind":"person","name":"Jones Jeffrey Alan","position":1,"cik":"0001914647","reported_name":"Jones Jeffrey Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-02-23T22:00:15.000Z","date":"2024-02-22","kind":"grant","planned":false,"acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares underlying the restricted stock unit vest on an annual basis over four years."}],"balance_after":118691,"source":{"system":"sec-edgar","filing":"0000950170-24-019455","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000095017024019455/ownership.xml","form_type":"4"}},{"id":1700567,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":64670,"kind":"person","name":"Jones Jeffrey Alan","position":1,"cik":"0001914647","reported_name":"Jones Jeffrey Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-12-22T22:30:14.000Z","date":"2023-12-21","kind":"sale","planned":false,"acquired":false,"shares":1860,"price":8.5,"value":15810.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover personal income tax obligations upon vesting of restricted stock units."}],"balance_after":56191,"source":{"system":"sec-edgar","filing":"0000950170-23-072756","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000095017023072756/ownership.xml","form_type":"4"}},{"id":1703098,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":64670,"kind":"person","name":"Jones Jeffrey Alan","position":1,"cik":"0001914647","reported_name":"Jones Jeffrey Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-12-20T23:00:16.000Z","date":"2023-12-18","kind":"sale","planned":false,"acquired":false,"shares":386,"price":8.22,"value":3172.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover personal income tax obligations upon vesting of restricted stock units."}],"balance_after":58051,"source":{"system":"sec-edgar","filing":"0000950170-23-071987","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000095017023071987/ownership.xml","form_type":"4"}},{"id":1847404,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":64670,"kind":"person","name":"Jones Jeffrey Alan","position":1,"cik":"0001914647","reported_name":"Jones Jeffrey Alan","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-06-21T20:17:46.000Z","date":"2023-06-20","kind":"sale","planned":false,"acquired":false,"shares":387,"price":12.94,"value":5007.78,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover personal income tax obligations upon vesting of restricted stock units."}],"balance_after":58437,"source":{"system":"sec-edgar","filing":"0000950170-23-029161","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000095017023029161/ownership.xml","form_type":"4"}},{"id":1883960,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":64670,"kind":"person","name":"Jones Jeffrey Alan","position":1,"cik":"0001914647","reported_name":"Jones Jeffrey Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-05-19T20:46:58.000Z","date":"2023-05-18","kind":"sale","planned":false,"acquired":false,"shares":394,"price":8.76,"value":3451.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover personal income tax obligations upon vesting of restricted stock units."}],"balance_after":58824,"source":{"system":"sec-edgar","filing":"0000899243-23-013361","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000089924323013361/doc4.xml","form_type":"4"}},{"id":1916209,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":64670,"kind":"person","name":"Jones Jeffrey Alan","position":1,"cik":"0001914647","reported_name":"Jones Jeffrey Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-04-20T20:38:37.000Z","date":"2023-04-18","kind":"sale","planned":false,"acquired":false,"shares":392,"price":10.71,"value":4198.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover personal income tax obligations upon vesting of restricted stock units."}],"balance_after":59218,"source":{"system":"sec-edgar","filing":"0000950170-23-013705","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000095017023013705/ownership.xml","form_type":"4"}},{"id":1937605,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":64670,"kind":"person","name":"Jones Jeffrey Alan","position":1,"cik":"0001914647","reported_name":"Jones Jeffrey Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-03-27T20:05:28.000Z","date":"2023-03-20","kind":"sale","planned":false,"acquired":false,"shares":390,"price":11.32,"value":4414.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover personal income tax obligations upon vesting of restricted stock units."}],"balance_after":59610,"source":{"system":"sec-edgar","filing":"0000899243-23-009717","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000089924323009717/doc4.xml","form_type":"4"}},{"id":2002743,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":64670,"kind":"person","name":"Jones Jeffrey Alan","position":1,"cik":"0001914647","reported_name":"Jones Jeffrey Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-21T23:51:31.000Z","date":"2023-02-17","kind":"grant","acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the option vest over four years, with one forty-eighth (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date."}],"balance_after":120000,"derivative":{"exercise_price":11.34,"expiration_date":"2033-02-16","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0000899243-23-005728","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000089924323005728/doc4.xml","form_type":"4"}},{"id":2002742,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":64670,"kind":"person","name":"Jones Jeffrey Alan","position":1,"cik":"0001914647","reported_name":"Jones Jeffrey Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-02-21T23:51:31.000Z","date":"2023-02-17","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares underlying the restricted stock unit vest over four years, with one forty-eighth (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date."}],"balance_after":60000,"source":{"system":"sec-edgar","filing":"0000899243-23-005728","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000089924323005728/doc4.xml","form_type":"4"}},{"id":2359198,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":64670,"kind":"person","name":"Jones Jeffrey Alan","position":1,"cik":"0001914647","reported_name":"Jones Jeffrey Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-03T00:05:49.000Z","date":"2022-02-28","kind":"grant","acquired":true,"shares":215000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option represents a right to purchase a total of 215,000 shares of the Issuer's Common Stock, 25% of which will become fully vested and exercisable on February 28, 2023, with the remaining shares vesting in equal monthly installments over the following three years thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":215000,"derivative":{"exercise_price":14.34,"expiration_date":"2032-02-27","underlying":"Common Stock","underlying_shares":215000},"source":{"system":"sec-edgar","filing":"0000899243-22-008730","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000089924322008730/doc4.xml","form_type":"4"}}]}